Human Oral Keratinocytes (HOK)

Human Oral Keratinocytes (HOK)

Cat.No.: CSC-7745W

Species: Human

Source: Oral Cavity

Cell Type: Keratinocyte

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-7745W
Description
Human Oral Keratinocytes (HOK) from Creative Bioarray are isolated from human oral mucosa. HOK are cryopreserved on passage one culture and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. HOK are characterized by immunofluorescent method with antibodies to cytokeratine-8, -18 and -19. HOK are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HOK are guaranteed to further expand for 15 population doublings in the condition provided by Creative Bioarray.
Species
Human
Source
Oral Cavity
Cell Type
Keratinocyte
Disease
Normal
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human Oral Keratinocytes (HOK) originate from human oral mucosal tissues specifically from the buccal mucosa, gingiva, and tongue areas. Located in the basal layer of oral mucosa these cells divide and differentiate to create new epithelial cells which replace aged or damaged ones. Basal layer cells move toward the surface through migration until they develop into keratinized or non-keratinized epithelial layers. HOK exhibit typical epithelial morphology, adhering to surfaces and growing into multi-layered structures, demonstrating excellent stratification properties. In vitro, HOK can form multi-layered keratinized epithelial models that mimic the natural structure of human oral mucosa.

The barrier function of the oral mucosa depends crucially on the activity of HOK. These cells activate immune responses and repair tissues through the secretion of multiple cytokines including IL-1α, IL-6, and VEGF. Additionally, HOK have the ability to respond to external stimuli including hypoxic conditions and show changes in their undifferentiated phenotype. During oral disease studies researchers utilize HOK to understand the development of oral cancer and oral ulcers and gingivitis while also assessing drug and oral care product safety and effectiveness. Tissue engineering uses these cells to develop oral mucosal tissue models which help researchers investigate tissue regeneration and repair processes. Furthermore, HOK are employed to assess the toxic effects of chemicals and drugs on oral mucosa.

Photomicrographs of human oral keratinocytes.Fig. 1. Photomicrographs of HOK (light microscope with 400x magnification) (Islam R, Jackson C, et al., 2015).

LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT/β-catenin signaling pathway

Journal of Cellular and Molecular Medicine | DOI | Paper |

Background

This study demonstrates that lncRNA LINC00941 is upregulated in oral squamous cell carcinoma (OSCC) through EP300-mediated promoter H3K27 acetylation. LINC00941 then loops to the CAPRIN2 promoter, activating CAPRIN2 expression. Functionally, LINC00941 and CAPRIN2 promote OSCC cell proliferation, colony formation, and in vivo tumor growth. Mechanistically, this axis activates canonical WNT/β-catenin signaling. The findings identify LINC00941/CAPRIN2/WNT/β-catenin as potential therapeutic targets and highlight LINC00941 as an oncogenic lncRNA in OSCC progression.

Key Findings

The study identifies LINC00941 as an oncogenic lncRNA in OSCC. It shows LINC00941 is upregulated in OSCC cell lines and patient tumor tissues compared with normal oral keratinocytes and normal tongue tissues. Mechanistically, EP300 binds the LINC00941 promoter and mediates H3K27 acetylation, driving LINC00941 transcription; EP300 depletion or HAT-domain deletion reduces LINC00941 expression. Upregulated LINC00941 interacts with the CAPRIN2 promoter via CTCF-dependent DNA looping, increasing CAPRIN2 expression. Silencing LINC00941 or deleting CAPRIN2 suppresses OSCC cell proliferation, colony formation, and cell cycle progression, while LINC00941 knockdown also reduces tumor formation in nude mice. CAPRIN2 upregulation is positively correlated with LINC00941 in patient samples. The LINC00941/CAPRIN2 axis activates canonical WNT/β-catenin signaling, increasing β-catenin, phosphorylated LRP6, and downstream MYC, CCND1, and SOX9; non-canonical WNT genes are unaffected. CAPRIN2 overexpression or WNT3a rescues proliferation defects caused by LINC00941 depletion. Thus, LINC00941 promotes OSCC progression through CAPRIN2 and canonical WNT/β-catenin signaling.

Contribution

Creative Bioarray supplied normal oral keratinocyte HOK cells used as non-malignant controls. These cells enabled comparisons showing OSCC-specific LINC00941 upregulation, H3K27ac enrichment, and EP300-dependent activation. HOK cells were essential for validating tumor-selective epigenetic regulation and establishing the oncogenic role of LINC00941 in OSCC.

LINC00941/CAPRIN2 activates canonical WNT signaling pathway.
Fig. 1. LINC00941/CAPRIN2 activates canonical WNT signaling pathway.

HOKs Challenged by Streptococcus sanguinis and Porphyromonas gingivalis Differentially Affect the Chemotactic Activity of THP-1 Monocytes

The transition from symbiotic microbe-host relationships to dysbiosis starts periodontal diseases which then lead to tissue destruction through a disrupted host response. The study by Li's team assessed how human oral keratinocytes (HOKs) exposed to either periodontal commensal bacteria or pathogens differentially impacted THP-1 monocyte chemotaxis.

Using a transwell migration assay, HOKs were challenged with S. sanguinis or P. gingivalis, and the mixed cultures were analyzed for THP-1 monocyte migration over 2 and 18 hours.  Figure 1 demonstrates that the count of stained THP-1 cells in the lower compartment varied significantly between different groups. The control group featuring HOKs alone managed to attract a substantial number of THP-1 cells. THP-1 cell attraction by HOKs increased after S. sanguinis challenge but reduced following P. gingivalis challenge compared to control. The THP-1 cell count in the S. sanguinis-HOKs group exceeded the count in the P. gingivalis-HOKs group by more than tenfold which indicates a significant difference. Importantly, neither S. sanguinis nor P. gingivalis alone effectively attracted THP-1 cells compared to the blank control. After 18 hours of interaction, a similar pattern persisted among all groups (Fig. 2), with the S. sanguinis-HOKs group continuing to show markedly greater attraction, while the P. gingivalis-HOKs group attracted significantly fewer THP-1 cells, about 15 times lower than the S. sanguinis group.

Chemotactic Response of THP-1 Cells after 2 Hours.Fig. 2. Chemotactic Effect on THP-1 Cells at 2 h (Li H, Seneviratne C J, et al., 2022).

Chemotactic Response of THP-1 Cells after 18 Hours.Fig. 3. Chemotactic Effect on THP-1 cells at 18 h (Li H, Seneviratne C J, et al., 2022).

Quercetin Attenuates LPS-Induced Human Oral Keratinocytes Injury

Quercetin produces anti-inflammatory effects but it remains uncertain whether these benefits apply to patients with oral lichen planus (OLP) because this common chronic mucocutaneous disease involves immune-mediated disease processes. Wang et al. developed a cell-based OLP model where HOKs were exposed to LPS to investigate the treatment potential of quercetin by examining downstream miRNAs and associated signaling pathways.

They first studied quercetin's effects on healthy human oral keratinocytes (HOKs) by exposing cell cultures to different quercetin concentrations to measure their viability. Cell viability remained stable when exposed to concentrations up to 100 μM but showed significant decline when concentrations reached between 200 and 400 μM (Fig. 3a). All following experiments utilized a quercetin maximum dose of 100 μM. Subsequent experiments treated HOKs with 100 ng/mL LPS while testing the presence or absence of 100 μM quercetin. LPS altered the levels of p53, p61, and cyclin D1 (Fig. 3b and c); quercetin effectively restored cell viability reduced by LPS (Fig. 3d); and LPS heightened apoptosis rates (Fig. 3e); while also changing Bax and cleaved caspases 3 and 9 levels (Fig. 3f and g). The findings demonstrate that quercetin can successfully reduce injury in HOK cells caused by LPS.

Quercetin reduces LPS-induced damage in HOKs.Fig. 4. Qu attenuates LPS-induced HOK injury (Wang F, Ke Y, et al., 2020).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products